272 related articles for article (PubMed ID: 9972639)
21. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
Newman M; Adityanjee ; Jampala C
Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
[No Abstract] [Full Text] [Related]
22. Two cases of risperidone-induced neuroleptic malignant syndrome.
Singer S; Richards C; Boland RJ
Am J Psychiatry; 1995 Aug; 152(8):1234. PubMed ID: 7542838
[No Abstract] [Full Text] [Related]
23. A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.
Ochi S; Kawasoe K; Abe M; Fukuhara R; Sonobe K; Kawabe K; Ueno S
Gen Hosp Psychiatry; 2011; 33(6):640.e1-2. PubMed ID: 21749835
[TBL] [Abstract][Full Text] [Related]
24. Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine.
Isbister GK; Dawson AH; Whyte IM
Ann Pharmacother; 2002; 36(7-8):1293; author reply 1294. PubMed ID: 12086569
[No Abstract] [Full Text] [Related]
25. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
Srivastava A; Borkar HA; Chandak S
Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
[TBL] [Abstract][Full Text] [Related]
26. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
[TBL] [Abstract][Full Text] [Related]
27. [Neuroleptic malignant syndrome--a case report].
Lanczik M; Fritze J
Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
[TBL] [Abstract][Full Text] [Related]
28. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
Illing M; Ancill R
Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
[No Abstract] [Full Text] [Related]
29. A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
Hsu WC; Lin ST; Chen CC; Tsang HY; Huang MF
J Clin Psychopharmacol; 2011 Oct; 31(5):667-9. PubMed ID: 21881455
[No Abstract] [Full Text] [Related]
30. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
Hasan S; Buckley P
Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
[TBL] [Abstract][Full Text] [Related]
31. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection.
Mitchell BG; McMahon BC; Mitchell CW
Prim Care Companion CNS Disord; 2017 Nov; 19(6):. PubMed ID: 29195036
[No Abstract] [Full Text] [Related]
32. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
Robb AS; Chang W; Lee HK; Cook MS
J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
[TBL] [Abstract][Full Text] [Related]
33. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
[No Abstract] [Full Text] [Related]
34. Caution is still needed when prescribing atypical antipsychotics.
Carey S
Br J Hosp Med (Lond); 2008 May; 69(5):299. PubMed ID: 18557562
[No Abstract] [Full Text] [Related]
35. Follow-up of a pregnancy with risperidone microspheres.
Dabbert D; Heinze M
Pharmacopsychiatry; 2006 Nov; 39(6):235. PubMed ID: 17124649
[TBL] [Abstract][Full Text] [Related]
36. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
Tanii H; Fujita K; Okazaki Y
Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
[No Abstract] [Full Text] [Related]
37. Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: a case report.
Lee SI; Klesmer J; Hirsch BE
Psychosomatics; 2000; 41(5):453-4. PubMed ID: 11015640
[No Abstract] [Full Text] [Related]
38. Novel antipsychotics and neuroleptic malignant syndrome.
Buckley P
Psychiatr Serv; 1996 Apr; 47(4):431. PubMed ID: 8689381
[No Abstract] [Full Text] [Related]
39. Neuroleptic malignant syndrome associated with clozapine use.
Anderson ES; Powers PS
J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
[TBL] [Abstract][Full Text] [Related]
40. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
Tsai JH; Yang P; Yen JY; Chen CC; Yang MJ
Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
